TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 3 | -1 | -5 | -12 | -13 | 43 | 3 |
| S | %wins | 0 | 50 | 100 | 100 | 100 | 0 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/13/09 21:37 | 8/11/09 | AVNR | Avanir Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Vivo Ventures Fund Vi, L.P. | CA | T | S | -986 | 3.49 | 7 | -282 | -3 | 8,050 | S | 2 | -6 | -2 | -13 | -17 | 32 | |||||||||
8/3/09 21:46 | 7/28/09 | AVNR | Avanir Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Vivo Ventures Fund Vi, L.P. | CA | T | S.m | -956 | 2.33 | 1 | -411 | -5 | 8,332 | 4 | 5 | -8 | -11 | -9 | 53 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |